1. Home
  2. RGEN vs OLED Comparison

RGEN vs OLED Comparison

Compare RGEN & OLED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • OLED
  • Stock Information
  • Founded
  • RGEN 1981
  • OLED 1985
  • Country
  • RGEN United States
  • OLED United States
  • Employees
  • RGEN N/A
  • OLED N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • OLED Semiconductors
  • Sector
  • RGEN Health Care
  • OLED Technology
  • Exchange
  • RGEN Nasdaq
  • OLED Nasdaq
  • Market Cap
  • RGEN 7.6B
  • OLED 7.2B
  • IPO Year
  • RGEN N/A
  • OLED 1992
  • Fundamental
  • Price
  • RGEN $156.55
  • OLED $145.96
  • Analyst Decision
  • RGEN Buy
  • OLED Strong Buy
  • Analyst Count
  • RGEN 12
  • OLED 7
  • Target Price
  • RGEN $187.44
  • OLED $207.86
  • AVG Volume (30 Days)
  • RGEN 470.1K
  • OLED 595.4K
  • Earning Date
  • RGEN 02-19-2025
  • OLED 02-20-2025
  • Dividend Yield
  • RGEN N/A
  • OLED 1.10%
  • EPS Growth
  • RGEN N/A
  • OLED 15.56
  • EPS
  • RGEN N/A
  • OLED 4.98
  • Revenue
  • RGEN $633,513,000.00
  • OLED $643,711,000.00
  • Revenue This Year
  • RGEN $2.28
  • OLED $12.60
  • Revenue Next Year
  • RGEN $9.88
  • OLED $11.48
  • P/E Ratio
  • RGEN N/A
  • OLED $29.30
  • Revenue Growth
  • RGEN N/A
  • OLED 9.63
  • 52 Week Low
  • RGEN $113.50
  • OLED $143.25
  • 52 Week High
  • RGEN $211.13
  • OLED $237.00
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 60.07
  • OLED 36.42
  • Support Level
  • RGEN $149.15
  • OLED $143.25
  • Resistance Level
  • RGEN $160.64
  • OLED $158.91
  • Average True Range (ATR)
  • RGEN 5.96
  • OLED 3.87
  • MACD
  • RGEN 0.91
  • OLED 0.38
  • Stochastic Oscillator
  • RGEN 79.57
  • OLED 17.31

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About OLED Universal Display Corporation

Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. A large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.

Share on Social Networks: